BGM did a 1-for-30 reverse split on Oct 1, 2026. Fund positions use its last close before the split, $0.2520 on Sep 30, 2026, until the new shares are matched.
QILIAN INTL HLDG GROUP LTD
BGM·G7307E123·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist
BGM (QILIAN INTL HLDG GROUP LTD) is held by 10 institutional investors as of Q2 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($36,198), XTX Topco Ltd ($23,192), UBS Group AG ($21,214). Net institutional sentiment: Mixed.
10
Holders
$135,185
Total Value
60% (10)
Consensus
6 buying - 4 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 12, 2026 · Insiders none · Activists May 28, 2025 · Congress none
ActivistSBSihai Ban10.9%May 28, 2025
ActivistXLXing Lai10.9%May 28, 2025
ActivistLTLow Thia Yang20.7%May 27, 2025
Checking access…
Top Holders
Checking access…
| Action | ||||||
|---|---|---|---|---|---|---|
Increased | 98,472(+109.7%) | $36,198 | 0.0% | -95.49% | 22 | |
Increased | 63,089(+451.6%) | $23,192 | 0.0% | -49.85% | 31 | |
Increased | 57,646(+2853.2%) | $21,214 | 0.0% | -66.72% | 21 | |
New | 57,227 | $21,036 | 0.0% | -31.52% | 29 | |
New | 54,207 | $20,000 | 0.0% | -31.52% | 26 | |
Increased | 32,067(+103.8%) | $11,788 | 0.0% | -65.58% | 19 | |
Decreased | 1,499(-25.3%) | $1,000 | 0.0% | -90.23% | 0 | |
Decreased | 1,815(-8.5%) | $681 | 0.0% | -92.87% | 0 | |
Unchanged | 200 | $74 | 0.0% | -77.30% | 0 | |
Unchanged | 5 | $2 | 0.0% | -77.30% | 0 | |
Exited | 0(-100.0%) | $14,076 | 0.0% | -96.06% | 0 | |
Exited | 0(-100.0%) | $14,000 | 0.0% | -66.85% | 0 |
BGMQILIAN INTL HLDG GROUP LTDContinue exploring
Other Healthcare stocks held by institutions
UNHUNITEDHEALTH GROUP INC417 holders · $300.5B
LLYELI LILLY & CO416 holders · $881.6B
TMOTHERMO FISHER SCIENTIFIC INC401 holders · $151.5B
JNJJOHNSON & JOHNSON398 holders · $415.6B
DHRDANAHER CORP DEL395 holders · $98.9B
ISRGINTUITIVE SURGICAL INC394 holders · $111.8B
MRKMERCK & CO INC391 holders · $230.3B
ABBVABBVIE INC386 holders · $303.9B
BSXBOSTON SCIENTIFIC CORP386 holders · $52.4B
ABTABBOTT LABORATORIES383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer